|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
289,870,000 |
Market
Cap: |
69.23(B) |
Last
Volume: |
2,081,153 |
Avg
Vol: |
1,407,619 |
52
Week Range: |
$225.07 - $283.59 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 224 |
Guru Rank Value : 5.4 |
Guru Occurances : 3 |
|
|
|
|
|
|
|
Company Profile Becton, Dickinson and Company is a medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. Co.'s business segments are: BD Medical, which produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings; BD Life Sciences, which provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers; and BD Interventional, which provides vascular, urology, oncology and surgical products.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
8,597 |
9,836 |
17,573 |
47,101 |
Total Sell Value |
$2,028,812 |
$2,316,830 |
$4,382,400 |
$12,101,842 |
Total People Sold |
3 |
3 |
6 |
8 |
Total Sell Transactions |
4 |
5 |
10 |
16 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Neal Shana Carol |
EVP and Chief People Officer |
|
2024-04-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,921) |
16,389 |
|
- |
|
Spoerel Thomas J |
SVP,Controller&Chief Acct Off |
|
2024-03-14 |
4 |
S |
$238.29 |
$67,198 |
D/D |
(282) |
2,276 |
|
2% |
|
Ezell Antoine C |
EVP, President NA & CMO |
|
2024-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(282) |
9,320 |
|
- |
|
Spoerel Thomas J |
SVP,Controller&Chief Acct Off |
|
2024-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(36) |
2,558 |
|
- |
|
Garrison Michael David |
EVP & President Medical |
|
2024-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(178) |
7,096 |
|
- |
|
Jones Christopher Ian Montague |
Director |
|
2024-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
900 |
21,405 |
|
- |
|
Henderson Jeffrey William |
Director |
|
2024-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
900 |
5,568 |
|
- |
|
Ring Timothy M |
Director |
|
2024-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
900 |
56,890 |
|
- |
|
Fraser-Liggett Claire |
Director |
|
2024-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
900 |
22,696 |
|
- |
|
Byington Carrie L |
Director |
|
2024-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
900 |
2,855 |
|
- |
|
Scott Bertram L |
Director |
|
2024-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
900 |
35,197 |
|
- |
|
Brown William M |
Director |
|
2024-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
900 |
2,512 |
|
- |
|
Eckert R Andrew |
Director |
|
2024-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
900 |
8,124 |
|
- |
|
Burzik Catherine M |
Director |
|
2024-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
900 |
13,242 |
|
- |
|
Waldstreicher Joanne |
Director |
|
2024-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
900 |
1,323 |
|
- |
|
Shan David |
EVP and Chief ISC Officer |
|
2024-01-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(44) |
5,693 |
|
- |
|
Garrison Michael David |
EVP & President Medical |
|
2023-12-11 |
4 |
S |
$232.46 |
$288,018 |
D/D |
(1,239) |
7,274 |
|
-0% |
|
Byrd Richard |
EVP & President Interventional |
|
2023-11-28 |
4 |
S |
$238.47 |
$514,141 |
D/D |
(2,156) |
4,120 |
|
-4% |
|
Neal Shana Carol |
EVP and Chief People Officer |
|
2023-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(258) |
18,310 |
|
- |
|
Neal Shana Carol |
EVP and Chief People Officer |
|
2023-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,659 |
18,568 |
|
- |
|
Shan David |
EVP and Chief ISC Officer |
|
2023-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(149) |
5,737 |
|
- |
|
Shan David |
EVP and Chief ISC Officer |
|
2023-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
2,408 |
5,886 |
|
- |
|
Quinn Michelle |
EVP and General Counsel |
|
2023-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(440) |
4,955 |
|
- |
|
Quinn Michelle |
EVP and General Counsel |
|
2023-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
2,115 |
5,395 |
|
- |
|
Ezell Antoine C |
EVP, President NA & CMO |
|
2023-11-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,654) |
9,602 |
|
- |
|
863 Records found
|
|
Page 1 of 35 |
|
|